M. Angelos Stergiou's Insider Trades & SAST Disclosures

M. Angelos Stergiou's most recent trade in SELLAS Life Sciences Group Inc was a trade of 385,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 10, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
SELLAS Life Sciences Group...
Angelos M. Stergiou Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 385,750 385,750 - - Stock Option (Right to Buy)
SELLAS Life Sciences Group...
Angelos M. Stergiou Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 257,000 615,132 (12%) 5% 0 Common Stock
SELLAS Life Sciences Group...
Angelos M. Stergiou Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jan 2025 243,900 859,032 (16%) 4% 0 Common Stock
SELLAS Life Sciences Group...
M. Angelos Stergiou Director, President and CEO Other type of transaction at price $ 1.13 per share. 04 Dec 2024 28,289 358,132 (7%) 0% 1.1 31,967 Common Stock
SELLAS Life Sciences Group...
M. Angelos Stergiou Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2024 238,500 238,500 - - Stock Option (Right to Buy)
SELLAS Life Sciences Group...
Angelos Stergiou M. Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2024 159,000 376,421 (7%) 3% 0 Common Stock
SELLAS Life Sciences Group...
Angelos M. Stergiou Director, President and CEO Other type of transaction at price $ 1.08 per share. 06 Dec 2023 12,268 217,421 (4%) 0% 1.1 13,249 Class A Common Stock
SELLAS Life Sciences Group...
Angelos M. Stergiou Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 217,500 217,500 - - Stock Option (Right to Buy)
SELLAS Life Sciences Group...
Angelos M. Stergiou Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2023 58,000 219,689 (4%) 1% 0 Common Stock
SELLAS Life Sciences Group...
Angelos M. Stergiou Director, President and CEO Sale of securities on an exchange or to another person at price $ 2.61 per share. 05 Dec 2022 6,494 161,689 - 2.6 16,938 Class A Common Stock
SELLAS Life Sciences Group...
Angelos M. Stergiou Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 165,000 165,000 - - Stock Option (Right to Buy)
SELLAS Life Sciences Group...
Angelos M. Stergiou Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 44,000 165,167 (3%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades